2014Shiyong yaowu yu linchuangRequires access

Safety and efficacy of aspirin combined with warfarin in the treatment of coronary heart disease and atrial fibrillation

Pan Jian-shen

Open publisher page 0 citations

Abstract

Objective To observe the safety and efficacy of aspirin combined with warfarin in the treatment of coronary heart disease and atrial fibrillation. Methods 46 cases of patients with coronary heart disease and atrial fibrillation in our department from August 2012 to August 2013 were divided into observation group and control group,23cases in each group. The observation group received aspirin combined with warfarin treatment,the control group received warfarin treatment only. The incidence of thromboembolism,bleeding,and renal function of the two groups were compared. Results The incidene of thromboembolism,bleeding,and renal function changes had no significant differences between observation group and control group( P 0. 05). Conclusion Aspirin combined with warfarin treatment for coronary heart disease and atrial fibrillation has lower incidence of thrombosis,bleeding,but has no significant difference compared with warfarin alone.

About this research paper

What this paper is about

Objective To observe the safety and efficacy of aspirin combined with warfarin in the treatment of coronary heart disease and atrial fibrillation. Methods 46 cases of patients with coronary heart disease and atrial fibrillation in our department from August 2012 to August 2013 were divided into observation group and control group,23cases in each group. The observation group received aspirin combined with warfarin treatment,the control group received warfarin treatment only. The incidence of thromboembolism,bleeding,and renal function of the two groups were compared. Results The incidene of thromboembolism,bleeding,and renal function changes had no significant differences between observation group and control group( P 0. 05). Conclusion Aspirin combined with warfarin treatment for coronary heart disease and atrial fibrillation has lower incidence of thrombosis,bleeding,but has no significant difference compared with warfarin alone.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the safety and efficacy of aspirin combined with warfarin in the treatment of coronary heart disease and atrial fibrillation. Methods 46 cases of patients with coronary heart disease and atrial fibrillation in our department from August 2012 to August 2013 were divided into observation group and control group,23cases in each group. The observation group received aspirin combined with warfarin treatment,the control group received warfarin treatment only. The incidence of thromboembolism,bleeding,and renal function of the two groups were compared. Results The incidene of thromboembolism,bleeding,and renal function changes had no significant differences between observation group and control group( P 0. 05). Conclusion Aspirin combined with warfarin treatment for coronary heart disease and atrial fibrillation has lower incidence of thrombosis,bleeding,but has no significant difference compared with warfarin alone.

Key concepts: Medicine, Warfarin, Aspirin, Atrial fibrillation, Internal medicine, Cardiology, Incidence (geometry), Coronary heart disease

Related papers

Back to paper searchBrowse research topicsOriginal source
Safety and efficacy of aspirin combined with warfarin in the treatment of coronary heart disease and atrial fibrillation — Research Paper | ScholarLens